Bu Hayee
Overview
Explore the profile of Bu Hayee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
483
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gordon M, Nigam G, Sinopoulou V, Al Bakir I, Bateman A, Din S, et al.
BMJ Open Gastroenterol
. 2024 Nov;
11(1).
PMID: 39615897
Introduction: The evolving landscape of inflammatory bowel disease (IBD) necessitates refining colonoscopic surveillance guidelines. This study outlines methodology adopted by the British Society of Gastroenterology (BSG) Guideline Development Group (GDG)...
2.
Papaefthymiou A, Aslam N, Hussein M, Alzoubaidi D, Gross S, Serna A, et al.
Ann Gastroenterol
. 2024 Jul;
37(4):418-426.
PMID: 38974074
Background: Hemostatic powders are used as second-line treatment in acute gastrointestinal (GI) bleeding (AGIB). Increasing evidence supports the use of TC-325 as monotherapy in specific scenarios. This prospective, multicenter study...
3.
Jirapinyo P, Hadefi A, Thompson C, Patai A, Pannala R, Goelder S, et al.
Endoscopy
. 2024 Apr;
56(6):437-456.
PMID: 38641332
This joint ASGE-ESGE guideline provides an evidence-based summary and recommendations regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the management of obesity. The document was developed using...
4.
Jirapinyo P, Hadefi A, Thompson C, Patai A, Pannala R, Goelder S, et al.
Gastrointest Endosc
. 2024 Apr;
99(6):867-885.e64.
PMID: 38639680
This joint ASGE-ESGE guideline provides an evidence-based summary and recommendations regarding the role of endoscopic bariatric and metabolic therapies (EBMTs) in the management of obesity. The document was developed using...
5.
Bernth J, Zhang G, Malas D, Abrahams G, Hayee B, Liu H
Soft Robot
. 2024 Mar;
11(4):670-683.
PMID: 38484296
Colonoscopy is currently the best method for detecting bowel cancer, but fundamental design and construction have not changed significantly in decades. Conventional colonoscope (CC) is difficult to maneuver and can...
6.
Barua I, Wieszczy P, Kudo S, Misawa M, Holme O, Gulati S, et al.
NEJM Evid
. 2024 Feb;
1(6):EVIDoa2200003.
PMID: 38319238
BACKGROUND: Artificial intelligence using computer-aided diagnosis (CADx) in real time with images acquired during colonoscopy may help colonoscopists distinguish between neoplastic polyps requiring removal and nonneoplastic polyps not requiring removal....
7.
Calthorpe R, Goodchild N, Gleetus V, Premakumar V, Hayee B, Elliott Z, et al.
NIHR Open Res
. 2023 Oct;
3:18.
PMID: 37881465
Background: Gastrointestinal symptoms in cystic fibrosis (CF) are common and intrusive to daily life. Relieving gastrointestinal symptoms was identified as an important research priority and previously explored in an international...
8.
Iacucci M, Parigi T, Amor R, Meseguer P, Mandelli G, Bozzola A, et al.
Gastroenterology
. 2023 Mar;
164(7):1180-1188.e2.
PMID: 36871598
Background & Aims: Microscopic inflammation has significant prognostic value in ulcerative colitis (UC); however, its assessment is complex with high interobserver variability. We aimed to develop and validate an artificial...
9.
Nayagam J, Mandour M, Taylor A, Heneghan M, Dubois P, Hayee B, et al.
Clin Res Hepatol Gastroenterol
. 2022 Jun;
46(7):101980.
PMID: 35728760
Background & Aims: Autoimmune sclerosing cholangitis (ASC) is a childhood sclerosing cholangitis frequently associated with inflammatory bowel disease (IBD). We describe the IBD phenotype in ASC patients and associated liver...
10.
Nardone O, Bazarova A, Bhandari P, Cannatelli R, Daperno M, Ferraz J, et al.
United European Gastroenterol J
. 2022 Feb;
10(2):147-159.
PMID: 35194978
Background And Aims: A composite endoscopic-histologic remission is increasingly explored as an important endpoint in ulcerative colitis (UC). We investigated combined endoscopic-histologic remission for predicting clinical outcomes at 12 months...